CMT Research Foundation funds Shift to explore novel series of drugs created to control the expression of PMP22 gene Overland Park: In late January, the CMT Research Foundation (CMTRF) announced a partnership with Shift Pharmaceuticals … Continue reading Shift Pharmaceuticals partners with CMT Research Foundation to further research CMT1A treatment